Market Overview

UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT on Allscripts Healthcare Solutions

Share:
Related MDRX
Watch These 7 Huge Call Purchases In Monday Trade
Benzinga's Option Alert Recap From June 23

In a report published Friday, Jefferies & Company reiterated its Hold rating on Allscripts Healthcare Solutions (NASDAQ: MDRX), and raised its price target from $10.50 to $13.00.

Jefferies noted, “Dismal 3Q results were attributed to customer hesitation on MDRX's a) corporate future and b) NT product future. The acknowledgment of a deal process puts a floor in the stock. Maybe even drives some upside. Many long-awaited releases go GA this month, but NT impact on bookings is questionable. 2012 guidance was withdrawn. A lower go-forward tax rate and share count offset nearly all of our reduction in 2013 pre-tax income.”

Allscripts Healthcare Solutions closed on Thursday at $12.26.

Latest Ratings for MDRX

DateFirmActionFromTo
Jun 2017Leerink SwannDowngradesOutperformMarket Perform
May 2017Bank of AmericaInitiates Coverage OnNeutral
Mar 2017Wells FargoUpgradesMarket PerformOutperform

View More Analyst Ratings for MDRX
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings

 

Related Articles (MDRX)

View Comments and Join the Discussion!